MRSH Stock Forecast: Marsh & McLennan Cos., Inc. Price Predictions for 2026-2027
The 23 Wall Street analysts covering Marsh & McLennan Cos., Inc. hold a median 12-month price target of $201 — +4.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 60 of 100 as at 1 Aug 2026 — in the upper half.
MRSH stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Marsh & McLennan Cos., Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (99): The share price has been relatively steady.
Momentum (37): The shares have been drifting down relative to others.
Size (3): Larger than most of the companies we track — more scrutinised, less often mispriced.
The rank is the raw material. Whether the rules would actually own Marsh & McLennan Cos., Inc. — and when they’d sell — is the membership.
MRSH stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on MRSH, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +4.2% from it.
Of the 20 most recent actions, 7 moved their price target up and 2 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 27 July 2026 | UBS | Maintains | Buy | $212 → $216 |
| 22 July 2026 | Citigroup | Downgrade | Neutral | $200 |
| 22 July 2026 | Mizuho | Maintains | Neutral | $197 → $201 |
| 22 July 2026 | Wells Fargo | Maintains | Equal-Weight | $186 → $188 |
| 13 July 2026 | JP Morgan | Maintains | Overweight | — |
| 13 July 2026 | JP Morgan | Maintains | Overweight | $206 → $212 |
| 10 July 2026 | Evercore ISI Group | Maintains | Outperform | — |
| 10 July 2026 | Evercore ISI Group | Maintains | Outperform | $236 → $234 |
| 9 July 2026 | Cantor Fitzgerald | Maintains | Overweight | $210 → $218 |
| 9 July 2026 | Cantor Fitzgerald | Maintains | Overweight | — |
| 9 July 2026 | Mizuho | Maintains | Neutral | — |
| 9 July 2026 | Mizuho | Maintains | Neutral | $194 → $197 |
| 8 July 2026 | UBS | Maintains | Buy | — |
| 8 July 2026 | UBS | Maintains | Buy | $203 → $212 |
| 6 July 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 6 July 2026 | Morgan Stanley | Maintains | Equal-Weight | $180 → $175 |
| 9 June 2026 | UBS | Maintains | Buy | — |
| 26 May 2026 | Piper Sandler | Maintains | Neutral | — |
| 6 May 2026 | Citigroup | Upgrade | Buy | — |
| 17 Apr 2026 | Keefe, Bruyette & Woods | Maintains | Market Perform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
MRSH analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Marsh & McLennan Cos., Inc. (MRSH) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 23.2×
- Price / sales
- 3.2×
- Price / book
- 6.0×
- EV / EBITDA
- 14.4×
Cheaper than 34% of US stocks
Cheaper than 39% of US stocks
Cheaper than 18% of US stocks
Cheaper than 25% of US stocks
- Revenue growth (YoY)
- 6.2%
- Earnings growth (YoY)
- 4.5%
- Gross margin
- 44.1%
- Operating margin
- 26.3%
- Net margin
- 14.2%
Higher than 44% of US stocks
Higher than 43% of US stocks
Higher than 56% of US stocks
Higher than 86% of US stocks
Higher than 77% of US stocks
- Return on equity
- 25.9%
- Return on assets
- 7.2%
- Dividend yield
- 2.1%
Higher than 86% of US stocks
Higher than 86% of US stocks
Higher than 47% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
MRSH vs competitors
The nearest names by industry and size, scored by the same model — like for like.
| Company | Market cap | TKN rank |
|---|---|---|
| MRSHMarsh & McLennan Cos., Inc. | $90.5B | 60 |
| AONAon plc | $77.2B | 52 |
| AJGArthur J. Gallagher & Co. | $64.1B | 13 |
| WTWWillis Towers Watson plc | $31.6B | 47 |
| BROBrown & Brown, Inc. | $23.9B | 15 |
| ERIEErie Indemnity Co. | $11.3B | 21 |
| KKRKKR & Co., Inc.* | $91.1B | 59 |
* Nearest Financial Services names by size — few insurance brokers companies of this scale trade in the US universe.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. MRSH appears on the weeks it earns a place.
Frequently asked questions about MRSH stock
What is the MRSH stock price forecast for 2026-2027?
The 23 Wall Street analysts covering Marsh & McLennan Cos., Inc. have a median 12-month price target of $201, with estimates ranging from $180 to $238. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is MRSH stock a buy right now?
Of the 23 analysts covering Marsh & McLennan Cos., Inc., 7 rate it a Buy, 15 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Marsh & McLennan Cos., Inc. 60 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank MRSH?
As at 1 Aug 2026, Marsh & McLennan Cos., Inc. ranks 60 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (99 of 100).
Will MRSH stock go up?
No one can know that. What the data says: the median 12-month target from 23 analysts implies +4.2% from the last close, and Ticker Nerd's factor model ranks Marsh & McLennan Cos., Inc. 60 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the MRSH stock forecast for 2030?
No analyst covering Marsh & McLennan Cos., Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for MRSH are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $180 to $238 over the next 12 months.
How has MRSH stock performed over the past year?
Marsh & McLennan Cos., Inc. returned -0.5% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Marsh & McLennan Cos., Inc. do?
Marsh & McLennan Companies, Inc. is a global professional services firm specializing in risk, insurance brokerage, reinsurance, health, wealth, and management consulting.
About Marsh & McLennan Cos., Inc.
Marsh & McLennan Companies, Inc. is a global professional services firm specializing in risk, insurance brokerage, reinsurance, health, wealth, and management consulting. The company focuses on providing advice and solutions in the areas of risk, strategy, and people to corporate, government, and institutional clients, as well as individual and consumer segments worldwide. Marsh & McLennan Companies, Inc. operates through two main segments: Risk and Insurance Services, and Consulting. The Risk and Insurance Services segment, delivered primarily through Marsh and Guy Carpenter, offers risk management advisory, insurance and reinsurance broking, risk transfer, and capital solutions for a broad range of industries and public entities. The Consulting segment, driven by Mercer and Oliver Wyman, provides health, wealth, and career consulting, alongside specialized management, economic, strategic, and brand advisory services. Headquartered in New York City and founded in 1871, Marsh & McLennan Companies, Inc. plays a central role in global financial and commercial markets by helping clients assess, manage, and optimize risk and human capital across regions and sectors.
CEO Mr. John Quinlan Doyle · 95,000 employees · United States · https://www.corporate.marsh.com